Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2019-08-16
Original SEC Filing: Click here

---

Webplus: SVA/20190816/6-K/2_EX-99.1/000.htm SEC Original: tv527791_ex99-1.htm
Sinovac Reports Unaudited Second Quarter 2019 Financial Results BEIJING, China, August 15, 2019 /Business Wire/ — Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the second quarter ended June 30, 2019. Second Quarter and First Half of 2019 Financial Summary Ÿ Sales for the

---

---

Webplus: SVA/20190816/6-K/1/000.htm SEC Original: tv527791_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2019-08-16CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200